Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2026 | Insights into the most anticipated changes in myeloma imaging over the next 5 years

Jens Hillengass • 23 Sep 2026
IMS 2026

Jens Hillengass, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, discusses anticipated advances in multiple myeloma imaging, highlighting the potential of artificial intelligence (AI) to improve image analysis and detect subtle changes. Dr Hillengass also hopes for technological improvements that will increase sensitivity and complement MRD testing. This interview took place at the 23rd International Myeloma Society (IMS) Annual Meeting in Glasgow, UK.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Jens Hillengass

Clinical implications of imaging in myeloma
1:08
Clinical implications of imaging in myeloma
Jens Hillengass • 14 Sep 2019
Whole-body low-dose CT in myeloma
2:44
Whole-body low-dose CT in myeloma
Jens Hillengass • 14 Sep 2019
Specialised imaging in multiple myeloma
1:05
Specialised imaging in multiple myeloma
Jens Hillengass • 14 Sep 2019
The exciting field of imaging in multiple myeloma
6:48
The exciting field of imaging in multiple myeloma
Jens Hillengass et al. • 18 Oct 2017

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals